Early Recognition of Renal Toxicity of High-dose Methotrexate Therapy A Case Report

被引:10
作者
Nowicki, Theodore Scott [1 ]
Bjornard, Kari [1 ]
Kudlowitz, David [1 ]
Sandoval, Claudio [1 ]
Jayabose, Somasundaram [1 ]
机构
[1] Maria Fareri Childrens Hosp, New York Med Coll, Dept Pediat, Div Pediat Hematol Oncol, Valhalla, NY 10595 USA
关键词
high-dose methotrexate; HDMTX; renal toxicity; carboxypeptidase G; leucovorin; osteosarcoma;
D O I
10.1097/MPH.0b013e318182e73e
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
A 10-year-old boy with osteosarcoma and normal renal function manifested laboratory evidence of impending renal toxicity and extreme elevation of aspartate aminotrasferase and alanine aminotransferase within 2 hours after the completion of a 4-hour infusion of high-dose methotrexate (MTX) (12g/m(2)), and went on to develop acute renal failure with life-threatening hyperkalemia 29 hours later. Although his renal function recovered completely with high-dose leucovorin, hemodialysis, charcoal hemoperfusion, and carboxypeptidase G2, we present this case to emphasize that signs of renal toxicity may be present as early as 2 hours after the completion of a 4-hour MTX infusion, and to Suggest that monitoring for MTX toxicity should perhaps begin within a few hours after the completion of 4-hour MTX infusion.
引用
收藏
页码:950 / 952
页数:3
相关论文
共 10 条
[1]   Carboxypeptidase G2 rescue in patients with methotrexate intoxication and renal failure [J].
Buchen, S ;
Ngampolo, D ;
Melton, RG ;
Hasan, C ;
Zoubek, A ;
Henze, G ;
Bode, U ;
Fleischhack, G .
BRITISH JOURNAL OF CANCER, 2005, 92 (03) :480-487
[2]   Severe acute toxicity associated with high-dose methotrexate (MTX) therapy:: use of therapeutic drug monitoring and test-dose to guide carboxypeptidase G2 rescue and MTX continuation [J].
Esteve, M. -A. ;
Devictor-Pierre, B. ;
Galy, G. ;
Andre, N. ;
Coze, C. ;
Lacarelle, B. ;
Bernard, J. -L. ;
Monjanel-Mouterde, S. .
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2007, 63 (01) :39-42
[3]   High-dose leucovorin as sole therapy for methotrexate toxicity [J].
Flombaum, CD ;
Meyers, PA .
JOURNAL OF CLINICAL ONCOLOGY, 1999, 17 (05) :1589-1594
[4]  
FRAPPAZ D, 1988, PRESSE MED, V17, P1209
[5]   Influence of high-dose meth trexate therapy (HD-MTX) on glomerular and tubular kidney function [J].
Hempel, L ;
Misselwitz, J ;
Fleck, C ;
Kentouche, K ;
Leder, C ;
Appenroth, D ;
Rost, M ;
Zintl, F .
MEDICAL AND PEDIATRIC ONCOLOGY, 2003, 40 (06) :348-354
[6]   The effect of malignant effusions on methotrexate disposition [J].
Li, J ;
Gwilt, P .
CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2002, 50 (05) :373-382
[7]   Effective removal of methotrexate by high-flux hemodialysis [J].
Saland, JM ;
Leavey, PJ ;
Bash, RO ;
Hansch, E ;
Arbus, GS ;
Quigley, R .
PEDIATRIC NEPHROLOGY, 2002, 17 (10) :825-829
[8]   High-dose methotrexate-induced nephrotoxicity in patients with osteosarcoma - Incidence, treatment, and outcome [J].
Widemann, BC ;
Balis, FM ;
Kempf-Bielack, B ;
Bielack, S ;
Pratt, CB ;
Ferrari, S ;
Bacci, G ;
Craft, AW ;
Adamson, PC .
CANCER, 2004, 100 (10) :2222-2232
[9]   Carboxypeptidase-G(2), thymidine, and leucovorin rescue in cancer patients with methotrexate-induced renal dysfunction [J].
Widemann, BC ;
Balis, FM ;
Murphy, RF ;
Sorensen, JM ;
Montello, MJ ;
OBrien, M ;
Adamson, PC .
JOURNAL OF CLINICAL ONCOLOGY, 1997, 15 (05) :2125-2134
[10]   Understanding and managing methotrexate nephrotoxicity [J].
Widemann, Brigitte C. ;
Adamson, Peter C. .
ONCOLOGIST, 2006, 11 (06) :694-703